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Abstract
Plants rely heavily on receptor-like kinases (RLKs) for perception and integration of external and internal stimuli. The
Arabidopsis regulatory leucine-rich repeat RLK (LRR-RLK) BAK1 is involved in steroid hormone responses, innate immunity,
and cell death control. Here, we describe the differential regulation of three different BAK1-dependent signaling pathways
by a novel allele of BAK1, bak1-5. Innate immune signaling mediated by the BAK1-dependent RKs FLS2 and EFR is severely
compromised in bak1-5 mutant plants. However, bak1-5 mutants are not impaired in BR signaling or cell death control. We
also show that, in contrast to the RD kinase BRI1, the non-RD kinases FLS2 and EFR have very low kinase activity, and we
show that neither was able to trans-phosphorylate BAK1 in vitro. Furthermore, kinase activity for all partners is completely
dispensable for the ligand-induced heteromerization of FLS2 or EFR with BAK1 in planta, revealing another pathway specific
mechanistic difference. The specific suppression of FLS2- and EFR-dependent signaling in bak1-5 is not due to a differential
interaction of BAK1-5 with the respective ligand-binding RK but requires BAK1-5 kinase activity. Overall our results
demonstrate a phosphorylation-dependent differential control of plant growth, innate immunity, and cell death by the
regulatory RLK BAK1, which may reveal key differences in the molecular mechanisms underlying the regulation of ligand-
binding RD and non-RD RKs.
Citation: Schwessinger B, Roux M, Kadota Y, Ntoukakis V, Sklenar J, et al. (2011) Phosphorylation-Dependent Differential Regulation of Plant Growth, Cell Death,
and Innate Immunity by the Regulatory Receptor-Like Kinase BAK1. PLoS Genet 7(4): e1002046. doi:10.1371/journal.pgen.1002046
Editor: David S. Guttman, University of Toronto, Canada
Received December 3, 2010; Accepted February 21, 2011; Published April 28, 2011
Copyright:  2011 Schwessinger et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: MR was the recipient of a Marie Curie Early Stage Training fellowship (MEST-CT-2005-019727). YK is a recipient of the grants KAKENHI 21870044, Riken
Special Postdoctoral Research Fellowship, and Excellent Young Researchers Overseas Visit Program from Japan Society for the Promotion of Science. This research
was funded by the Gatsby Charitable Foundation (CZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of
the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: cyril.zipfel@tsl.ac.uk
Introduction
Plants are under constant pressure to respond rapidly and
accurately to changing environmental and developmental condi-
tions. Hence they need to translate extracellular signals into
appropriate intracellular responses. Cell surface receptor-like-
kinases (RLKs) are one of the major components in this
extracellular sensing. The model plant species Arabidopsis and
rice show a huge expansion of the RLK family compared to other
eukaryotes with .600 and .1100 members, respectively [1].
However, only a very limited number of plant RLKs have an
assigned function ranging from development to responses to biotic
and abiotic stresses [2–4].
Plant RLKs share a common domain organization with the
well-studied mammalian receptor tyrosine kinases (RTKs) [5,6].
The activation of RTKs is initiated by ligand binding to the extra-
cellular domain leading to conformational changes that are
transmitted by a single trans-membrane domain and induce
receptor homo- and/or hetero-oligomerization [7]. This leads to
activation by trans- and auto-phoshorylation of the activation
loop, correct positioning of the cytoplasmic asymmetric kinase
dimer, and release of the inhibition by the C-terminal and/or
juxta-membrane regions [8–10]. Downstream signaling is initiated
by sequential auto- or trans-phosphorylation of specific residues in
the cytoplasmic domain serving as docking sites for downstream
signaling partners, and/or direct phosphorylation of signaling
substrates [11].
Kinases, including RLKs, can be subdivided into RD and non-
RD kinases depending on the conservation of the amino-acid
residue preceding the core catalytic aspartate (Asp) residue in
subdomain VIb of the kinase domain [12,13]. Most RD kinases
require auto-phosphorylation of the activation loop for full kinase
activity. In contrast, non-RD kinases do not require activation
loop phosphorylation and are activated by different mechanisms
[13].
Notably, several plant RD- and non-RD ligand-binding
receptor kinases (RKs) share the common RD-type regulatory
RLK BAK1 as signaling partner [14,15]. The leucine-rich repeat
(LRR)-RLK BAK1 (At4g33430) is a member of the somatic
embryogenesis-related kinase (SERK) family and is also named
SERK3 [16,17]. BAK1 was initially identified as a positive
regulator of brassinosteroid (BR) responses, forming a ligand-
dependent complex in vivo with the LRR-RK BRI1 (At4g39400),
the main BR receptor [18–21]. Over-expression of BAK1
suppresses weak bri1 alleles, and bak1 knock-out mutants are
hypo-sensitive to BR and resemble weak bri1 alleles [18,19,21].
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mutants have a spreading lesion phenotype upon pathogen
infection and premature senescence [22,23]. This loss of cell
death control is aggravated in double-mutant combinations with
its closest paralog BKK1/SERK4 (At2g13790), and strong bak1
bkk1 allele combinations are seedling lethal even in sterile
conditions [22,24]. Additionally, BAK1 interacts with BIR1
(At5g48380), another LRR-RLK, mutants of which also show
constitutive uncontrolled cell death [25].
BAK1 was also identified as an important regulator of
pathogen-associated-molecular-pattern (PAMP)-triggered immu-
nity (PTI) [26,27]. Bak1 null mutants are compromised in their
responsiveness to several PAMPs including flg22 (derived from
bacterial flagellin), elf18 (derived from bacterial EF-Tu), HrpZ,
lipopolysaccharides, peptidoglycans, and damage-associated mo-
lecular patterns (DAMPs), such as AtPep1 [26–29]. Furthermore,
BAK1-silenced Nicotiana benthamiana (N. benthamiana) plants are less
sensitive to the PAMPs INF1 and csp22 (derived from bacterial
cold shock protein) [26]. BAK1 rapidly forms ligand-dependent
heteromers with the flg22 and elf18 pattern-recognition receptors
(PRRs), the ligand-binding LRR-RKs FLS2 (At5g46330) and EFR
(At5g20480), respectively [26,27,30](Roux et al., submitted). BAK1
also interacts in a ligand-independent manner with the AtPep1
PRRs, the ligand-binding LRR-RKs AtPEPR1/2 (At1g73080/
At1g17750) in yeast two-hybrid assays [15]. The importance of the
heteromerization with BAK1 in plant innate immunity is
substantiated by the targeting of the ligand-induced BAK1-FLS2
interaction by the bacterial virulence effector AvrPto to block PTI
signaling [29,31,32] Importantly, the function of BAK1 in cell
death control and innate immunity seems to be independent of its
function in BR signaling [14].
Clearly, BAK1 is an important regulator implicated in multiple
independent signaling pathways leading to growth, cell death
control and innate immunity. Although BAK1 forms ligand-
dependent heteromers with several ligand-binding LRR-RKs
[20,21,26,27], it is not required for ligand binding [27,33]. In
that respect, BAK1 should be considered as a regulatory RLK
rather than a co-receptor. It is, however, not fully understood how
BAK1 regulates these different pathways.
A previous study suggests that BAK1 functions as a signal
enhancer for the RD-kinase BRI1 [21]. This conclusion is based
on biochemical studies into auto- and trans-phosphorylation
events revolving around BRI1-BAK1 followed by phenotypic
analysis of BAK1 phospho-mimetic and phospho-dead mutants.
Interestingly none of the BAK1 mutant alleles had a strong
differential effect on PTI and BR signaling [21]. The activation of
BAK1 by BRI1 is further supported by a recent report showing
that a tyrosine auto-phosphorylation site in the C-terminus of
BAK1 is required for trans-activation of BRI1 [34]. Interestingly,
this auto-phoshorylation site of BAK1 is not required for flg22-
induced seedling growth inhibition (SGI) [34]. Given this
differential requirement of phosphosites and the different mode
of regulation of non-RD kinases versus RD kinases [12,13], it is
unclear whether the BRI1-BAK1 model can be generalized to
non-RD kinases. Since non-RD kinases are mostly associated with
functions in innate immunity across kingdoms [35], it is of great
interest to elucidate potential regulatory mechanisms of non-RD
kinases and to reveal potential differences to RD kinases.
Here, we demonstrate the phosphorylation-dependent differen-
tial regulation of the RD-kinase BRI1 and the non-RD kinases
FLS2 and EFR by BAK1. We identified a novel mutant allele of
BAK1, bak1-5, that is strongly impaired in PTI signaling but
displays a wild-type-like BR signaling capacity. Furthermore, bak1-
5 is not impaired in cell death control. This unexpected phenotype
is not due to a differential complex formation between BAK1-5
and the RD and non-RD kinases, but requires the kinase activity
of BAK1-5 suggesting a phosphorylation-dependent differential
regulation. Moreover, our work reveals dramatic differences in the
trans-phosphorylation events between BAK1 and BRI1 or EFR in
vitro, and the requirement of kinase activity for complex formation
in planta.
Results
Identification of the novel BAK1 allele bak1-5
To identify novel regulators of EFR function/signaling in
Arabidopsis thaliana, we previously performed a forward-genetic
screen for elf18-insensitive (elfin) mutants based on loss SGI triggered
by elf18 [36]. Out of 103 non-efr elfin mutants recovered, only one,
elfin27-6, showed a clear defect in the SGI induced by both elf18
and flg22, even at high peptide concentrations (1 mM) (Figure 1A,
Figure S1). This suggested that this mutant was affected in an
important component shared by both EFR- and FLS2-dependent
signaling pathways.
Using a map-based cloning approach we identified the
corresponding mutation as a single mis-sense substitution in the
10
th exon of BAK1 (Figure 1B). We therefore tentatively renamed
elfin27-6 as bak1-5. This mutation leads to a C408Y change in the
subdomain VIa of the cytoplasmic kinase preceding the catalytic
loop (Figure 1C). This Cys residue is conserved in ,17% of all
RLKs in Arabidopsis thaliana (data not shown).
Next, we tested whether the bak1-5 mutation affects the
accumulation of the BAK1 protein. To this end, we performed
immunoblot analysis on protein extracts of Col-0, bak1-5 and bak1-
4 (SALK_116202) mutant plants using anti-BAK1 antibodies. As
shown in Figure 1D, full-length mutant BAK1-5 protein
accumulated to similar levels as the wild-type protein, whereas
the corresponding band was completely missing in bak1-4 null
mutants.
To confirm that the C408Y mutation causes the observed elfin
phenotype, we first transformed the null mutant bak1-4 with BAK1
Author Summary
Plants need to adapt to their ever-changing environment
for survival. Transmembrane receptor kinases are essential
to translate extracellular stimuli into intracellular respons-
es. A key question is how plants maintain signaling
specificity in response to multiple stresses and endoge-
nous hormones. Growth responses induced by steroid
hormones and innate immunity triggered by recognition
of conserved microbial molecules depend on the common
regulatory receptor-like kinase BAK1, which is also involved
in cell death control. It is still unclear if BAK1 provides
signaling specificity or if it is a mere signaling enhancer.
Here, we describe the novel protein variant BAK1-5 that
specifically blocks innate immune responses without
affecting steroid responses or cell death. This unambigu-
ously demonstrates that the role of BAK1 in plant signaling
can be mechanistically separated. Importantly, the impair-
ment of immune signaling is not caused by a loss of
interaction of BAK1-5 with immune receptors but is due to
an altered kinase activity. Thus, BAK1-dependent signaling
pathways are under a differential phosphorylation-depen-
dent regulation. The examination of this novel mutant
version of BAK1 will enable detailed studies into the
mechanistic role of BAK1 in plant innate immunity, but
also more generally will provide invaluable insights into
transmembrane receptor signaling specificity in plants.
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regulatory sequences. As expected, the wild-type transgene was
able to complement the compromised flg22- and elf18-induced
reactive oxygen species (ROS) burst of bak1-4 (Figure 1E and
Figure S2A–S2B). Consistently, transgenic plants expressing
BAK1-5 were strongly impaired in flg22- and elf18-induced ROS
burst and thus phenocopied the bak1-5 mutant (Figure 1E and
Figure S2A–S2B).
To further prove that the bak1-5 mutation causes the elfin
phenotype, and to ascertain whether bak1-5 is a recessive or
dominant mutation, we took advantage of the fact that bak1-4,i n
contrast to bak1-5 (Figure 1A and Figure S1), is not impaired in the
SGI triggered by elf18 (Figure 1F and Figure S1) [27]. We tested
the contribution of BAK1-5 to the impaired elf18-induced SGI in
an allelism test between bak1-5 and bak1-4. Only homozygous
bak1-5 and bak1-56bak1-4 heterozygous F1 seedlings showed a
strong impairment in elf18-induced SGI (Figure 1F). Interestingly
bak1-56Col-0 heterozygous F1 plants showed an intermediate
phenotype between wild-type Col-0 and bak1-5 seedlings
(Figure 1F). This indicates that bak1-5 is a semi-dominant allele
and suggests that BAK1-5 has as a dose-sensitive dominant-
negative effect on the endogenous wild-type BAK1. This semi-
dominant-negative effect was not restricted to SGI, but was also
observed when elf18-induced ROS burst was measured in leaves
of bak1-56Col-0 heterozygous F1 plants (Figure S2C).
Therefore, bak1-5 is a novel semi-dominant allele of BAK1 with
a specific phenotype related to PAMP responsiveness.
bak1-5 is strongly impaired in EFR- and FLS2-dependent
PTI signaling
Previous results showed that the null bak1-4 mutant plants were
strongly impaired in early and late responses to flg22, but were not
impaired in late elf18 responses [27]. In particular, elf18-induced
SGI in bak1-4 was indistinguishable from wild-type (Figure 1 E and
Figure S1) [27]. Since the novel allele bak1-5 was impaired in both
flg22- and elf18-triggered SGI, we investigated the impact of the
bak1-5 mutation on early and late responses triggered by flg22 and
elf18.
Figure 1. elfin27-6 is a novel allele of BAK1. A. elfin27-6 is impaired in seedling growth inhibition triggered by 60 nM elf18 or flg22. Fresh weight
is represented relative to untreated control. Results are average 6 s.e (n=6). B. elfin27-6 carries a single mis-sense mutation in the 10
th exon of BAK1.
Schematic representation of relative marker positions and observed recombination rates in a Ler-06elfin27-6 F2 mapping population. C. Cys408 is
conserved in all AtSERK family members but not in all RLKs. Alignment of kinase subdomains VIa, VIb and VII of AtSERKs, AtBRI1, AtCLV1, AtFLS2,
AtEFR and OsXA21. The star indicates the Cys to Tyr change in BAK1-5. D. BAK1-5 accumulates to wild-type levels. Immunoblot of total protein from
Col-0, bak1-5 and bak1-4 using anti-BAK1 antibody. Immunoblot, upper panel; Coomassie colloidal blue stained membrane, lower panel. E. The bak1-
5 mutation is causative for the reduced flg22-induced ROS burst. Total ROS burst in leaves of Col-0, bak1-4, bak1-5, bak1-4 pBAK1::BAK1, and bak1-4
pBAK1::BAK1-5 after treatment with 100 nM flg22. Results are average 6 s.e. (n=8). F. bak1-5 is a semi-dominant allele. Seedling growth inhibition of
Col-0, bak1-4, bak1-5, bak1-56bak1-4 F1 and bak1-56Col-0 F1 in the presence of 10 nM elf18. Fresh weight is represented relative to untreated
control. Results are average 6 s.e (n=6). These experiments were repeated at least three times with similar results.
doi:10.1371/journal.pgen.1002046.g001
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treatment was strongly reduced in bak1-5 leaves (Figure 2A),
whereas leaves of the null mutant bak1-4 showed only a delayed
and slightly reduced ROS burst (Figure 2A), as previously reported
[26,27].
Next, we analysed the impact of bak1-5 on the activation of
MAP kinases (MPKs) by flg22 and elf18. Consistent with previous
observations, the activation of MPK3, 4 and 6 after flg22 and elf18
treatment was delayed and reduced in bak1-4 seedlings (Figure 2B).
Surprisingly, the activation of these MPKs by flg22 and elf18 was
differentially regulated in bak1-5 seedlings. The activation of
MPK3 and 6 by flg22 and elf18 was also delayed, but the level of
activation ultimately reached levels similar to that observed in
wild-type seedlings at 15 mins. Notably, MPK4 was not activated
at all during the time-course of the experiment (Figure 2B).
Since MPK activation is linked to PAMP-induced transcrip-
tional reprogramming [37,38] we then assessed whether PAMP-
induced gene expression was also affected in bak1-5 seedlings using
three different PTI marker genes [39] over a 3-hour time-course
experiment. The induction of the three genes by flg22 and elf18
was partially impaired in bak1-4 over the time-course although this
effect was minor at certain time-points (Figure 2C). In contrast,
after flg22 or elf18 treatment the transcript levels of all three PTI-
marker genes were drastically reduced in bak1-5 over the time-
course (Figure 2C). Interestingly, the steady-state expression of the
marker genes was already significantly lower in bak1-5 when
compared to wild-type (Figure S3).
Our results clearly demonstrate that bak1-5 plants were strongly
affected in all flg22 and elf18 responses measured. Strikingly, the
new allele bak1-5 was more strongly impaired in PTI signaling
than the null allele bak1-4 suggesting a mis-regulation of PTI
signaling. This effect was particularly apparent with EFR-
dependent responses, as bak1-4 null mutants were not affected in
elf18-triggered late responses, whereas bak1-5 mutants were.
Finally, we tested if the strong impairment of bak1-5 in EFR-
and FLS2-dependent PTI signaling compromised resistance to
Figure 2. bak1-5 is strongly impaired in EFR- and FLS2-dependent PTI signaling. A. bak1-5 is strongly impaired in flg22- and elf18-induced
ROS burst. ROS burst in leaves of Col-0, bak1-4, bak1-5 after treatment with 100 nM flg22 (upper panel) or elf18 (lower panel). Results are average 6
s.e. (n=8). B. Differential MPK activation in bak1-5 after flg22 and elf18 treatment. The kinetics of kinase activation in seedlings of Col-0, bak1-4 and
bak1-5 treated with either 100 nM flg22 (upper panel) or elf18 (lower panel) as shown by immunoblot analysis using an anti-p44/42-ERK antibody.
Individual MPKs are identified by molecular mass and indicated by arrows. Immunoblot, upper panel; Coomassie colloidal blue stained membrane,
lower panel. C. Defence gene induction by flg22 and elf18 is strongly impaired in bak1-5. Gene expression of At2g17740 (upper panel), CYP81F2
(middle panel) and At1g51890 (lower panel) in seedlings of Col-0, bak1-4 and bak1-5 treated with 100 nM flg22 or 100 nM elf18 was measured by
qPCR analysis. Results are average 6 s.e. (n=3). D. bak1-5 is hyper-susceptible to Pseudomonas syringae pv. tomato (Pto) DC3000 COR
-. Four-week old
plants (Col-0, fls2, efr, fls2 efr, bak1-4 and bak1-5) were spray-inoculated and bacterial count measured 3 d.p.i.. Results are average 6 s.e. (n=4). ‘‘a’’,
‘‘b’’, or ‘‘c’’ above the graph denotes statistically significant difference p,0.05 (ANOVA, Newman-Kleus post test). These experiments were repeated at
least three times with similar results.
doi:10.1371/journal.pgen.1002046.g002
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old plants with the weakly virulent strain Pto DC3000 COR
2 that
has been previously shown to be compromised in fully suppressing
PTI signaling [40]. Consistently, bacteria grew to slightly higher
titters in leaves of PRR single mutants fls2 or efr, and to even
higher levels in the double mutant fls2 efr when compared to wild-
type (Figure 2D). As reported previously [23], bak1-4 mutants were
as susceptible as wild-type to bacterial spray-infection (Figure 2D);
most likely due to the only slight impairment in PTI signaling and
the compromised cell death control [23]. In contrast, bak1-5 plants
were hyper-susceptible and supported bacterial multiplication to
similar levels as in efr fls2 leaves (Figure 2D). The impairment of
bak1-5 in bacterial resistance was further supported by the
increased disease symptoms observed after spray-infection with
Pto DC3000 COR
2 (Figure S4). In addition, Col-0, bak1-4 and
bak1-4 plants expressing BAK1 displayed no significant disease
symptoms after spray-infection with Pto DC3000 COR
-, whereas
bak1-5 or bak1-4 plants expressing BAK1-5 clearly develop
chlorotic lesions associated with disease (Figure S4).
Therefore, the compromised PTI signaling capacity of bak1-5
leads to a reduced ability to launch effective defence responses
culminating in hyper-susceptibility to bacteria.
bak1-5 is not impaired in brassinosteroid signaling
Next, we tested if bak1-5 was also impaired in BR signaling, as
all previously reported bak1 loss-of-function alleles are hyposensi-
tive to BR [18,19]. Classically, the reported bak1 loss-of-function
alleles display a semi-dwarf cabbage-like rosette when grown
under short-day conditions similar to weak bri1 mutant plants
[18,19]. Surprisingly, bak1-5 plants did not show any growth
impairment under these conditions and looked comparable to
wild-type plants (Figure 3A). Consistently, the expression of both
BAK1 and BAK1-5 was able to rescue the semi-dwarf cabbage-
like rosette phenotype of bak1-4 (Figure S5).
As plant morphology does not always correlate with defects in
other BR responses [17], we compared the effect of exogenous
treatments with brassinolide (BL), the most bioactive BR [41], or
the BR biosynthesis inhibitor brassinazole (BRZ) [42] on bak1-4
and bak1-5 plants. First, we quantitatively investigated the BR-
responsiveness of etiolated seedlings grown under different BR
regimes [43]. As expected, bak1-4 hypocotyls were much smaller
than wild-type, were hypo-sensitive to the growth inhibition effect
of BL, and hyper-sensitive to BRZ (Figure 3B). In contrast,
although bak1-5 hypocotyls were slightly smaller than wild-type,
they displayed a wild-type-like responsiveness to BRZ and BL
(Figure 3B).
To test for subtle changes in BR sensitivity in the bak1-4 and
bak1-5 seedlings, we performed BL marker gene analysis by
quantitative real-time RT-PCR. For this purpose, we investigated
the expression pattern of two well-characterised BL marker genes,
SAUR-AC1 (At4g38850) as an auxin co-regulated gene, and EXP8
(At2g40610) as a BL-specific gene [44]. In order to fully capture the
signaling capability of either bak1 allele, we included a pre-
treatment with BRZ to reduce any hormone level adaptation
within genotypes that may have altered BR signaling capacity as
previously reported for bzr1-1D [45]. BL treatment on its own did
not reveal any significant differences between the genotypes for
EXP8 expression (Figure 3C, left). However, the induction of
SAUR-AC1 by BL was clearly impaired in bak1-4 and less so in
bak1-5 (Figure 3C, right). Interestingly, BRZ pre-treatment prior
to BL treatment revealed a clear impairment of bak1-4 in BL-
induced gene expression for both marker genes (Figure 3C). On
the contrary, bak1-5 showed an induction of SAUR-AC1 compa-
rable to wild-type (Figure 3C, right), and the induction of EXP8
appeared higher in bak1-5 than wild-type under this treatment
regime (Figure 3C, left).
Defects in BR sensitivity are often revealed when mutations in
potential BR signaling components or biosynthetic genes are
combined with weak bri1 alleles [46]. To test if the bak1-5 mutation
affects BR sensitivity in such assays, we crossed bak1-4 or bak1-5
with bri1-301 that carries a point mutation in the kinase domain of
BRI1 [47]. As previously reported [18], the bak1-4 mutation
increased the BR-related phenotypes of bri1-301, as measured by
rosette morphology of short-day-grown plants, hypocotyl length of
etiolated seedlings grown on BL- or BRZ-containing medium, and
morphology of long-day grown plants (Figure 3D–3F). In contrast,
the bak1-5 mutation did not aggravate the bri1-301 phenotype to
the same extent in any of these assays (Figure 3D–3F).
Surprisingly, as noted before with the expression of BL marker
genes in bak1-5 (Figure 3C), etiolated bri1-301 bak1-5 seedlings
appeared even slightly hyper-responsive to BL when compared to
bri1-301 (Figure 3E).
Overall, our results clearly demonstrate that the novel allele
bak1-5 is still fully sensitive to BR. This phenotype is in clear
contrast with the hypo-sensitivity generally associated with bak1
loss-of-function alleles.
bak1-5 is not impaired in cell death control
To test if bak1-5 is impaired in cell death control, we crossed
bak1-4 or bak1-5 with the null mutant bkk1-1 (SALK_057955) [24].
Twenty out of seventy individuals (X
2=0.476, p=0.49) from a
bak1-46bkk1-1 F2 segregating population died after two weeks in
long-day conditions on sterile MS plates. In contrast, none of bak1-
56bkk1-1 F2 segregating seedlings (n=76) died, and we could
isolate fully viable double mutants (Figure 4). Furthermore,
homozygous bak1-5 bkk1-1 plants showed no symptoms related
to cell death or early senescence when grown in non-sterile soil,
and this even at later stages of development (Figure S6).
The bak1-5 allele is therefore not associated with loss of cell
death control.
BAK1-5 shows an enhanced interaction with the ligand-
binding LRR-RKs FLS2, EFR, and BRI1
From our detailed phenotypic analysis (Figure 2, Figure 3,
Figure 4), it appears that bak1-5 is specifically affected in PTI
signaling. One hypothesis for the observed phenotypes could be
that BAK1-5 has a reduced interaction with the PRRs FLS2 and
EFR, but is still capable of interacting with the BR receptor BRI1.
To test this hypothesis, we performed co-immunoprecipitation
analyses between BAK1 and these receptors. Using specific anti-
FLS2 antibodies, we could detect a clear flg22-dependent complex
formation between FLS2 and BAK1 in wild-type Arabidopsis
seedlings (Figure 5A). Surprisingly, BAK1-5 was detected in FLS2
immunoprecipitates from non-elicited seedlings (Figure 5A). In
addition, the amount of BAK1-5 in complex with FLS2 after flg22
treatment was greater than in the case of BAK1 (Figure 5A).
Similar results were observed when we performed the reciprocal
immunoprecipitation experiment (Figure S7).
We recently demonstrated that BAK1 also forms a ligand-
dependent complex with EFR (Roux et al., submitted). Due to the
lack of specific anti-EFR antibodies that could be used for
immunoprecipitation experiments in Arabidopsis, we tested the
interaction of epitope-tagged BAK1 or BAK1-5 with EFR after
heterologous transient expression in the plant model N. benthami-
ana. After immunoprecipitation of BAK1-GFP using GFP-trap
beads we observed a clear elf18-dependent recruitment of EFR-
HA3 into the complex (Figure 5B). Interestingly, the amount of
BAK1 and Signaling Specificity
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treatment was higher than with BAK1-GFP (Figure 5B).
Next, we tested the interaction of BAK1-5 with BRI1 after
immunoprecipitation with specific anti-BRI1 antibodies
(Figure 5C). We were able to confirm the in planta BRI1-BAK1
interaction previously reported using transgenic lines expressing
epitope-tagged BRI1 and/or BAK1 proteins [18,20]. Surprisingly,
as observed with FLS2 and EFR, BAK1-5 also showed an
enhanced interaction with BRI1 (Figure 5C).
Importantly, BAK1-5 still retained its interaction specificity, as
it did not interact with CERK1, a LysM-RK involved in BAK1-
independent chitin perception [29,48,49], when co-expressed as
epitope-tagged proteins in N. benthamiana (Figure S8).
In contrast to our initial hypothesis, BAK1-5 has a higher
affinity than BAK1 for the ligand-binding LRR-RKs FLS2, EFR
and BRI1. This observation, together with the differential impact
of the bak1-5 mutation on PTI signaling triggered by FLS2 and
EFR, but not on BRI1-dependent responses (Figure 2 and
Figure 3. bak1-5 is not impaired in brassinosteroid signaling. A. bak1-5 plants have a wild-type-like morphology under short day conditions.
Picture of representative individuals of five-week-old Col-0, bak1-4 and bak1-5 plants grown under short-day conditions. Scale bar represents 5 cm. B.
bak1-5 shows a wild-type-like BL-induced hypocotyl growth inhibition in etiolated seedlings. Hypocotyl length of 5-day-old etiolated Col-0, bak1-4
and bak1-5 seedlings grown without or with 100 nM BRZ or 100 nM BL. Results are average 6 s.e. (n$30). C. bak1-5 shows a wild-type-like BL marker
gene induction. Col-0, bak1-4 and bak1-5 seedlings were pre-treated for 16 H with 2.5 mM BRZ or not before treatment with 100 nM BL or not for 3 H.
Gene expression of EXP8 (left) and SAUR-ACI (right) was measured by qPCR. Results are average 6 S.E. (n=3). D. bak1-5 does not aggravate the bri1-
301 cabbage-like rosette under short-day conditions. Picture of representative individuals of six-week-old bri1-301, bri1-301 bak1-4 and bri1-301 bak1-
5 plants grown under short-day conditions. Scale bar represents 5 cm. E. bak1-5 shows a wild-type-like morphology and does not enhance the bri1-
301 growth phenotype under long-day conditions. Picture of representative individuals of six-week-old Col-0, bak1-4, bak1-5, bri1-301, bri1-301 bak1-4
and bri1-301 bak1-5 plants grown under long-day conditions. Scale bar represents 5 cm. F. bri1-301 bak1-5 is slightly hyper-responsive to BL-induced
hypocotyl elongation of etiolated seedlings. Hypocotyl length of 5-day-old bri1-301, bri1-301 bak1-4 and bri1-301 bak1-5 etiolated seedlings grown
without or with 100 nM BRZ or 100 nM BL. Results are average 6 s.e. (n$16). These experiments were repeated at least twice with similar
results.
doi:10.1371/journal.pgen.1002046.g003
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explained by differences in complex formation.
BAK1-5 is a hypoactive kinase
Since the bak1-5 mutation corresponds to a C408Y amino acid
change just before the catalytic loop of the kinase domain
(Figure 1C), the bak1-5 phenotype could be due to altered kinase
activity.
To test potential differences in BAK1-5 kinase activity, we
expressed in Escherichia coli (E. coli) the cytoplasmic domains (CD:
residues 256 to 615) of BAK1 and BAK1-5, as well as the
respective kinase-dead mutant variants (D416N) (indicated as
BAK1* and BAK1-5*, respectively) as N-terminally tagged GST-
fusion proteins and purified them using glutathione beads. In
agreement with previous studies [18–21] we detected a strong
phosphorylation of BAK1 CD on threonine/serine and tyrosine
residues in vitro (Figure 6A–6B). This is due to the auto-
phosphorylation of BAK1 CD during recombinant protein
production and in the in vitro kinase assay as the phosphorylation
status of kinase dead BAK1* CD was negligible (Figure 6A–6B).
The phosphorylation status of BAK1-5 CD was slightly reduced
compared to BAK1 CD but still significantly higher than that of
kinase dead BAK1-5* CD (Figure 6A–6B). This is also illustrated
by the fact that both BAK1 CD and BAK1-5 CD showed a
mobility shift on SDS-PAGE compared to kinase inactive mutant
variants (Figure 6A–6B). Next, we quantified the reduction of
kinase activity of BAK1-5 by determining the auto-phosphoryla-
tion levels of BAK1 and BAK1-5 over an increasing concentration
range of ATP. As shown in Figure S9, BAK1-5 has an ,3.6-fold
reduction in kinase activity as the C408Y mutation in BAK1-5
lowers its Km to ,25 mM compared to ,7 mM in the case of
BAK1. These results demonstrate that BAK1-5 is an active kinase
albeit with a slightly reduced kinase activity when compared to
BAK1.
Figure 4. Cell death control is not compromised in bak1-5. Picture of representative individuals of 2.5 week-old seedlings of Col-0, bak1-4,
bak1-5, bkk1-1, bak1-4 bkk1-1 and bak1-5 bkk1-1. Scale bar represents 2 cm. These experiments were repeated at least three times with similar results.
doi:10.1371/journal.pgen.1002046.g004
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kinases EFR and FLS2 in their phosphorylation activities
BAK1 CD and BRI1 CD are active kinases that undergo auto-
and trans-phosphorylation when incubated together in vitro
[18,19,21]. Therefore, we studied the kinase activities of FLS2
CD and EFR CD, and the trans-phosphorylation events occurring
between them and the BAK1 CD.
We first analyzed FLS2 and EFR kinase activities and
compared them with the kinase activity of BRI1. For this
purpose, we expressed in E. coli the CDs of EFR (residues 682 to
1031), FLS2 (residues 840 to 1173) and BRI1 (residue 814 to
1196) as fusion proteins with an N-terminal maltose-binding
protein (MBP) tag. As controls, we also constructed the
respective kinase-dead variants EFR* CD (D849N), FLS2* CD
(D997N) and BRI1* CD (D1009N). We initially intended to
identify the phosphorylation status of FLS2 CD, EFR CD and
BRI1 CD using phospho-site specific antibodies either recogniz-
ing phosphorylated threonine/serine or tyrosine residues.
Unfortunately, we were unable to observe a signal specific to
the kinase active variants of FLS2 CD and EFR CD (data not
shown), therefore we restored to using radioactive [
32P]-c-ATP
in in vitro kinase assays. As previously reported [50], BRI1 CD
had a very strong auto- and trans-phosphorylation capacity using
the artificial substrate myelin basic protein (MBP) (Figure 7A). In
contrast, EFR CD possessed only minor auto-phosphorylation
capacity and negligible trans-phosphorylation ability on MBP
(Figure 7A). Notably, these activities were abolished in BRI1*
CD and EFR* CD (Figure 7A), demonstrating that the observed
Figure 5. BAK1-5 shows an enhanced interaction with ligand-binding RK FLS2, BRI1, and EFR. A. BAK1-5 shows a ligand-independent
interaction with FLS2 in A. thaliana. Co-immunoprecipitation of BAK1 or BAK1-5 with FLS2 in Col-0 or bak1-5 plants treated or not with 100 nM flg22
for 5 min, respectively. Total proteins (T) were subjected to immunoprecipitation (IP) with anti-FLS2 antibodies and IgG beads followed by
immunoblot analysis using either anti-FLS2 or anti-BAK1 antibodies. B. BAK1-5-GFP shows an enhanced interaction with EFR-HA3 in N. benthamiana.
Co-immunoprecipitation of leaves expressing EFR-HA3 with either BAK1-GFP or BAK1-5-GFP. Leaves were treated or not with 100 nM elf18 for 5 min.
Total proteins (T) were subjected to immunoprecipitation (IP) with GFP-Trap beads followed by immunoblot analysis using either anti-GFP or anti-HA
antibodies. The asterisk indicates an unspecific band. C. BAK1-5 shows an enhanced interaction with BRI1 in A. thaliana. Co-immunoprecipitation of
BAK1 or BAK1-5 with BRI1 in Col-0 or bak1-5 treated or not with 100 nM BL for 1.5 H, respectively. Total proteins (T) were subjected to
immunoprecipitation with anti-BRI1 antibodies and IgG beads followed by immunoblot analysis using either anti-BRI1 or anti-BAK1 antibodies. The
asterisk indicates an unspecific band. These experiments were repeated at least twice with similar results.
doi:10.1371/journal.pgen.1002046.g005
Figure 6. BAK1-5 is a hypoactive kinase in vitro. A. BAK1-5 CD is a hypoactive kinase on Ser and Thr residues. 0.25 mg of heterologously-
expressed N-terminal GST-tagged BAK1, BAK1-5, BAK1* and BAK1-5* CD were subjected to immunoblot analysis with anti-phospho-Thr antibodies.
Immunoblot, upper panel; Coomassie colloidal blue stained membrane, lower panel. B. BAK1-5 CD is a hypoactive kinase on Tyr residues. 0.75 mgo f
heterologously-expressed N-terminal GST-tagged BAK1, BAK1-5, BAK1* and BAK1-5* CD were subjected to immunoblot analysis with anti-phospho-
Tyr antibodies. Immunoblot, upper panel; Coomassie colloidal blue stained membrane, lower panel. These experiments were repeated at least twice
with similar results.
doi:10.1371/journal.pgen.1002046.g006
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of these protein.
Surprisingly, we were unable to detect any FLS2 CD
phosphorylation in vitro (Figure 7A), indicating that FLS2 is an
extremely weak kinase. The latter result is in disagreement with
previous reports that revealed phosphorylation activities in vitro for
FLS2 [31,50,51]. As Zhou and colleagues [31] used a N-terminally
His tagged FLS2 fusion protein to report FLS2 kinase activity, we
also generated His-FLS2 CD. Again, as observed with MBP-FLS2
CD, we were unable to observe any phosphorylation activity
(Figure S10). Under the same conditions, His-BRI1 CD displayed
a strong kinase activity (Figure S10).
Consequently, it appears that in comparison BRI1 is an
extremely strong kinase, EFR is a moderately good kinase, and
FLS2 is almost kinase-inactive in vitro. Therefore, we focused our
trans-phosphorylation studies with BAK1 and BAK1-5 on the
comparison between the non-RD kinase EFR and the RD kinase
BRI1.
We first confirmed in our experimental conditions that BAK1
CD was able to trans-phosphorylate BRI1* CD, and reciprocally
that BRI1 CD was able to trans-phosphorylate BAK1* CD
(Figure 7B). Also BAK1-5* CD was trans-phosphorylated by BRI1
CD and to a similar level compared to BAK1* CD (Figure 7B).
The reduced kinase activity of BAK1-5 CD lead to a lower level of
trans-phosphorylation of BRI1* CD when compared to BAK1 CD
(Figure 7B).
Next, we investigated the in vitro trans-phosphorylation events
surrounding EFR CD. We found that BAK1 CD was able to
trans-phosphorylate EFR* CD to a level much stronger than EFR
CD auto-phosphorylation (Figure 7C). This is in contrast to the
BAK1-BRI1 trans-phosphorylation events in which BAK1 CD
trans-phosphorylation of BRI1* CD is similar in comparison to
BRI1 CD auto-phosphorylation (Figure 7B). Another striking
difference was the inability of EFR CD to trans-phosphorylate
BAK1* CD (Figure 7C). Importantly, BAK1-5 CD was still able to
trans-phosphorylate EFR* CD and slightly enhanced the phos-
phorylation status of EFR CD (Figure 7C).
In summary, BAK1 trans-phosphorylates the non-RD kinase
EFR, but not the reverse. In contrast, the RD-kinase BRI1
undergoes a bi-directional trans-phosphorylation with BAK1 in
vitro as previously shown [19,21]. This is particularly interesting as
BAK1-5 displays a reduced trans-phosphorylation capacity for
both receptors in vitro but specifically blocks signaling events
mediated by the non-RD kinase EFR in vivo (Figure 2 and
Figure 3).
Kinase activitiy is not required for ligand-dependent
FLS2/EFR-BAK1 heteromerization
The kinase activity of BRI1 is strictly required for the ligand-
induced BRI1-BAK1 complex formation [21]. To determine
whether the in vivo heteromerization of BAK1 with FLS2 or EFR
requires the kinase activity of either partner, we co-expressed in N.
benthamiana wild-type and kinase-dead versions of FLS2, EFR and
BAK1 for co-immunoprecipitation experiments.
Clear ligand-dependent complex formation between the wild-
type BAK1 and FLS2 or EFR proteins could be detected
(Figure 8A–8B). Co-expressing BAK1*-HA3 with either FLS2-
GFP or EFR-GFP did not reduce the complex formation after
PAMP treatment when immunoprecipitating FLS2 or EFR using
GFP-trap beads (Figure 8). Similarly FLS2*-GFP and EFR*-GFP
Figure 7. Differential phosphorylation activity of BRI1 and BAK1 (RD-kinases) and FLS2 and EFR (non-RD kinases). A. Differential
kinase activity of the RD kinase BRI1 and the non-RD kinases FLS2 and EFR. In vitro kinase assay incubating equal amounts of MBP control or N-
terminal MBP-tagged EFR, EFR*, FLS2, FLS2*, BRI1 and BRI1* CD with artificial substrate myelin basic protein (MBP). Autoradiogram, upper panel;
Coomassie colloidal blue stained membrane, lower panel. B. BRI1 and BAK1 undergo bi-directional trans-phosphorylation in vitro. In vitro kinase assay
incubating equal amounts of N-terminal MBP-tagged BRI1 or BRI1* CD with N-terminal GST-tagged BAK1, BAK1*, BAK1-5, BAK1-5* CD or GST control,
respectively. Autoradiogram, upper panel; Coomassie colloidal blue stained membrane, lower panel. C. Uni-directional trans-phosphorylation of EFR
by BAK1 in vitro. In vitro kinase assay incubating equal amounts of N-terminal MBP-tagged EFR or EFR* CD with N-terminal GST-tagged BAK1, BAK1*,
BAK1-5, BAK1-5* CD or GST control, respectively. Autoradiogram, upper panel; Coomassie colloidal blue stained membrane, lower panel. These
experiments were repeated at least three times with similar results.
doi:10.1371/journal.pgen.1002046.g007
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expressed with BAK1-HA3 (Figure 8A–8B). Finally, we tested
double kinase-dead receptor combinations. After ligand addition,
both FLS2*-GFP and EFR*-GFP still interacted with BAK1*-HA3
as strongly as wild-type receptor combinations (Figure 8A–8B).
Thus, the kinase activities of neither FLS2/EFR nor BAK1 are
required for their ligand-induced heteromerization.
The kinase activity of BAK1-5 is required for the bak1-5
phenotype
We tested if the kinase activity of BAK1-5 is required for the
bak1-5 phenotype. As bak1-5 has the strongest differential
phenotype with elf18 response when compared to bak1-4,w e
concentrated on EFR-dependent responses to address this
question.
We created stable transgenic lines in the bak1-4 background
expressing BAK1, BAK1*, BAK1-5 and BAK1-5* under the
native regulatory sequence of BAK1 (Figure S11). The wild-type
allele of BAK1 was able to rescue the reduced and delayed elf18-
induced ROS burst of bak1-4 (Figure 9A). As previously shown
(Figure 1E), expression of BAK1-5 in bak1-4 recapitulated the
bak1-5 phenotype (Figure 9B). Interestingly, the expression of the
kinase inactive BAK1* in bak1-4 led to a further decrease in elf18-
induced ROS burst (Figure 9B), revealing a dominant-negative
effect of BAK1* and demonstrating the importance of BAK1
kinase activity for downstream signaling. Strikingly, the expression
of BAK1-5* in bak1-4 led to a similar dominant-negative effect as
BAK1* but did not fully suppress elf18-induced ROS burst as
observed in bak1-5 or when BAK1-5 was expressed in bak1-4
(Figure 9A). Similar results were observed in the SGI assay
(Figure 9B).
These two observations demonstrate that BAK1-5 requires its
kinase activity to quench EFR-dependent signaling. More
importantly, it strongly suggests that the differential impact of
the bak1-5 mutation on different signaling pathways is linked to
phosphorylation.
Discussion
Plants need to correctly process diverse exogenous and
endogenous information. For this purpose they rely heavily on
surface localised ligand-binding RKs and regulatory RLKs. In
recent years, the importance of the regulatory RLK BAK1
became apparent, as it is involved in several independent signaling
pathways, namely BR responses, innate immunity and cell death
control [14]. It was however unclear whether the regulatory role
and the importance of BAK1 in these different biological processes
are similar. Here, we clearly demonstrated that BAK1 differen-
tially regulates these pathways in a phosphorylation-dependent
manner.
Phosphorylation-dependent differential regulation of
BAK1-dependent BR and PTI signaling pathways
We found that bak1-5 mutant plants are impaired in all early
and late elf18- and flg22-triggered responses tested (Figure 1 and
Figure 2). Yet, bak1-5 possesses full signaling capacity for BR
Figure 8. The ligand-induced heteromerization of EFR and FLS2 with BAK1 is independent of kinase activity in planta. A. Elf18-
induced co-immunoprecipitation of EFR and BAK1 before (2) and after (+) elicitation with 100 nM elf18 in N. benthamiana transiently expressing EFR-
GFP-His or EFR*-GFP-His and BAK1-HA3 or BAK1*-HA3, as indicated. Total proteins were subjected to immunoprecipitation with anti-GFP beads
followed by immunoblot analysis with anti-GFP or anti-HA antibodies as indicated. B. Flg22-induced co-immunoprecipitation of FLS2 and BAK1
before (2) and after (+) elicitation with 100 nM flg22 in N. benthamiana transiently expressing FLS2-GFP-His or FLS2*-GFP-His and BAK1-HA3 or
BAK1*-HA3, as indicated. Total proteins were subjected to immunoprecipitation with anti-GFP beads followed by immunoblot analysis with anti-GFP
or anti-HA antibodies as indicated. These experiments were repeated twice with similar results.
doi:10.1371/journal.pgen.1002046.g008
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bak1 loss-of-function mutant alleles that are partially impaired in
early and late flg22-triggered responses, but only in early responses
triggered by elf18 (Figure 2; Figure S1) [26,27]. Importantly, bak1
loss-of-function mutants are also weakly impaired in BR signaling
(Figure 3; Figure S5) [18,19]. Our initial working hypothesis for
the differential regulation of BR and PTI signaling in bak1-5 was
based on a potential differential interaction of BAK1-5 with the
different ligand-binding RKs. However, this simple hypothesis did
not hold true as BAK1-5 displays an enhanced interaction with all
three ligand-binding RKs tested, namely FLS2, EFR and BRI1
(Figure 5). Therefore, we investigated the kinase activity of BAK1-
5 and were able to show that BAK1-5 possesses considerable
kinase activity albeit slightly reduced compared to BAK1.
Importantly, BAK1-5 was still able to trans-phosphorylate both
BRI1 and EFR in vitro (Figure 7B–7D). This raises the alternative
hypothesis that the reduced kinase activity of BAK1-5 is sufficient
to support BR but not PTI signaling. Yet several observations do
not support this hypothesis. First, there is no direct correlation
between the in vitro kinase activity of BAK1 mutant variants and
their ability to complement either the compromised flg22-
triggered SGI of bak1-4 bkk1-1 or the growth retardation
phenotype of bri1-5 [21]. BAK1(T449A) is able to complement
both phenotypes but has a reduced kinase activity compared to
BAK1(T450A) that is not able to complement either phenotype
[21]. Interestingly, BAK1-5 possesses a stronger kinase activity
than BAK1(T449A) (data not shown) further substantiating this
observation. Second, plants expressing the hypo-active kinase
variant BAK1(Y610F) are blocked only in BR signaling but not
flg22-triggered SGI [34] thereby displaying an opposite phenotype
to bak1-5 plants even though both BAK1 variants are compro-
mised in their overall kinase activity. Therefore, the quantitative
kinase output of BAK1 is not the determining factor per se that
enables BAK1 to function in PTI- or BR-signaling (Table S1).
Third, in bak1-5 plants PTI signaling is not simply more impaired
than in bak1-4 loss of function mutants but rather differentially
regulated. This is exemplified in the differential MPK activation in
bak1-5 plants whereby MPK3 and 6 but not MPK4 are fully
activated 15 mins after ligand-treatment (Figure 2B). Fourth,
BAK1-5 requires its kinase activity to fully suppress elf18-triggered
ROS-burst in vivo (Figure 9B).
Altogether, this leads to the new hypothesis that BAK1-5
differentially regulates PTI- and BR-signaling pathways by
discriminative auto-phosphorylation and/or trans-phosphoryla-
tion of the main-ligand binding receptors. Therefore, the
qualitative kinase output of BAK1 defines its signal competence
in respect to PTI- or BR- signaling pathways.
In the case of bak1-5 mutant plants, the differential auto-
phosphorylation of BAK1-5 could theoretically already lead to a
differential interaction surface for potential downstream signaling
components. Alternatively (or concomitantly), BAK1-5 could
trans-phosphorylate specific residues on EFR and FLS2 that
would affect interactions with positive and/or negative regulators,
such as BIK1 and related proteins [50,52]. Phosphorylation of
specific phosphosites in the intra-cellular juxta-membrane region
and C-terminal tail of mammalian RTKs and Ser/Thr RKs are
known to regulate signal complex composition, sub-cellular
localization, receptor degradation, and therefore the initiation,
amplitude, complexity and/or duration of the signal [53,54].
Interestingly, the rice PRR XA21 also seems to be under
phosphorylation-dependent negative regulation. The ATPase
XB24 interacts with XA21 in vivo, promotes XA21 auto-
phosphorylation in vitro, and is a negative regulator of XA21-
mediated immunity [55].
As observed previously for bak1 loss-of-function [23] and bak1-4
bkk1-1 plants expressing the phosphosite mutant variant BA-
K1(Y610F) [34], the basal expression level of several defence
marker genes was significantly reduced in bak1-5 (Figure S3). Since
BAK1-5 showed a reduced Tyr phosphorylation level in vitro
(Figure 6B) BAK1-5 may be unable to auto-phosphorylate on
Y610 and that BAK1 normally regulates basal gene expression via
phosphorylation of this specific amino acid. Alternatively, the
overall reduced kinase activity of both BAK1-5 and BAK1(Y610F)
may lead to a lower constitutive basal defence signaling either
induced by epiphytic bacteria and/or caused by spontaneous
kinase activity [53].
Regulation of BAK1-dependent cell death control
bak1-5 is not impaired in cell death control, as bak1-5 bkk1-1
double mutant is viable and do not show any cell death or early
senescence phenotypes (Figure 4 and Figure S6). This peculiarity is
currently difficult to interpret, as the role of BAK1 and BKK1 in
inducible and constitutive cell death control is still unclear. It was
initially speculated that BAK1 and BKK1 might negatively control
a ligand-binding RK perceiving a potential endogenous ‘‘survival’’
ligand [23,24,56]. Another LRR-RLK, BIR1, interacts with
Figure 9. BAK1-5 requires its kinase activity for suppression of elf18-induced responses. A. The kinase activity of BAK1-5 is required for
the suppression of elf18-induced ROS burst. ROS burst in leaves of Col-0, bak1-4, bak1-5, bak1-4 pBAK1::BAK1, bak1-4 pBAK1::BAK1-5 bak1-4,
pBAK1::BAK1* and bak1-4 pBAK1::BAK1-5* treated with 100 nM elf18. Results are average 6 s.e. (n=8). B. The kinase activity of BAK1-5 is required for
the suppression of elf18-induced SGI. SGI of Col-0, bak1-4, bak1-5, bak1-4 pBAK1::BAK1, bak1-4 pBAK1::BAK1-5 bak1-4, pBAK1::BAK1* and bak1-4
pBAK1::BAK1-5* in the presence of 60 nM elf18. Results are average 6 s.e. (n=6). These experiments were repeated at least twice with similar results.
doi:10.1371/journal.pgen.1002046.g009
BAK1 and Signaling Specificity
PLoS Genetics | www.plosgenetics.org 11 April 2011 | Volume 7 | Issue 4 | e1002046BAK1 in vivo and is strictly required for cell death control [25]. An
alternative model is suggested by the constitutive cell death
phenotype of bak1-4 bkk1-1 seedlings that is partially dependent on
salicylic acid [24], is light-dependent [56], and the fact that the
bir1-1 cell death phenotype is partially reverted by high
temperatures and mutations in PAD4 and EDS1 [25], components
classically associated with R protein-mediated hyper-sensitive
response [57]. The integrity and/or activity of a multimeric
complex containing BAK1, BKK1 and BIR1 may be ‘‘guarded’’
by an R protein. The absence of BAK1 and BKK1, or BIR1,
would thus trigger constitutive cell death and explain the mutant
seedling lethality even in sterile conditions. Interestingly though,
the kinase activity of BAK1 seems to be important for cell death
control, as kinase-dead variants of BAK1 cannot rescue the bak1-4
bkk1-1 lethality [21]. In this respect, it is not surprising that bak1-5
bkk1-1 is fully viable as only kinase inactive variants of BAK1 were
previously shown to be unable to complement the bak1-4 bkk1-1
lethality phenotype [21,34].
Differential regulation of RD and non-RD kinases
The differential impact of bak1-5 on BRI1-dependent and
FLS2/EFR-dependent signaling could also be related to a more
general differential regulation of RD versus non-RD kinases. RD
kinases carry an arginine (Arg) before the conserved catalytic core
Asp, and generally are activated by phosphorylation in the
activation loop. The phospho-groups interact with a positively-
charged pocket containing the Arg and most likely re-orient
residues within the catalytic loop, ATP-binding pocket and/or
facilitate peptide substrate binding [13]. In contrast, non-RD
kinases do not require phosphorylation of the activation loop to
adopt an active confirmation. They are regulated by different
mechanisms such as relief of auto-inhibition by C-terminal
extensions [58], Tyr phosphorylation in the P+1 loop [59], or
are constitutively active kinases [60]. In several cases the kinase
activity of non-RD kinases was shown to be at least partially
dispensable for some of their functions [35,61] suggesting a role as
scaffolds. However, EFR and FLS2 require kinase activity for
signaling, which implies that they do not function solely as
scaffolding proteins.
The RD-kinase BRI1 was far more active in vitro in our
conditions than the non-RD kinases EFR and FLS2 showing
strong auto- and trans-phosphorylation capacities (Figure 7A–7B).
EFR did possess some degree of auto-phosphorylation (Figure 7A,
7C), but no trans-phosphorylation capacity either towards the
artificial kinase substrate MBP (Figure 7A), or towards the
physiologically-relevant BAK1 kinase domain (Figure 7C). Sur-
prisingly, we were unable to detect any in vitro activity for FLS2
CD (residues 840 to 1173) neither as N-terminal MBP-tag nor His-
tag fusion protein, especially in comparison to the strong BRI1
kinase activity (Figure 7 and Figure S10). This is in contradiction
to previous observations that report kinase activity of FLS2 in vitro
[31,50,51], but is in agreement with recent publications reporting
only residual kinase activity of FLS2 CD (residues 832 to 1173)
and stating that recombinant FLS2 possess only weak kinase
activity impeding analysis of trans-phoshorylation events in vitro
[52]. Notably, close sequence analysis of the FLS2 kinase domain
revealed a low conservation of the otherwise highly conserved Gly-
rich loop [GxGxxG] in subdomain I, which is involved in the
correct positioning of the substrate ATP [62]. Particularly, the
replacement of the second invariant Gly by a Ser (S879) in FLS2 is
predicted to lead to a dramatic reduction in kinase activity, as
mutation of the corresponding Gly in the model Ser/Thr kinase
cAPK reduces the kinase activity by 50-fold [63].
In contrast to the situation with BRI1 and BAK1, no trans-
phosphorylation of BAK1 by EFR could be observed in vitro
(Figure 7B–7C). Yet, BAK1 is capable of trans-phosphorylating
EFR in vitro (Figure 7C). Of course, we cannot exclude that FLS2
and EFR kinase domains are only fully activated in vivo after
extracellular ligand binding via conformation changes mediated
by the trans-membrane domain, which is missing in the in vitro
system.
Consistent with their low activity in vitro, so far no phosphosites
could be identified by mass spectrometry on recombinant EFR or
FLS2 CDs, even when co-incubated with BAK1 (data not shown).
Even in the case of the well-studied non-RD kinase XA21, all
studied phosphorylation sites were initially found by targeted
mutagenesis and not by mass spectrometry analysis [64,65]. The
identification of specific phosphosites underlying the positive or
negative regulation of EFR and FLS2 therefore remain a real
technical challenge.
Nevertheless, the kinase activities and some potential phospho-
sites of FLS2 and EFR are important for several downstream
signaling events. A kinase-dead version of EFR (EFR*) is unable to
confer elf18-triggered ROS burst when transiently expressed in N.
benthamiana (Figure S12). A K898M mutation in the FLS2 kinase
domain abolished MPK3 and MPK6 activation by flg22 after
transient over-expression in fls2 mutant protoplasts [66]. Targeted
mutagenesis of potential phosphosites in FLS2 revealed that T867,
T1040 and T1072 are required for its full functionality [67].
However, it was not investigated if these sites are required for
kinase activity, are auto-phosphorylation sites, or whether they
represent trans-phophorylation targets of BAK1.
Overall, the striking difference between the kinase activities of
the two RD kinases BRI1 and BAK1 compared to the non-RD
kinases EFR and FLS2 suggests a different regulatory mechanism
between these two kinase classes. A highly conserved Thr residue
in the intracellular juxta-membrane domain reveals a differential
regulation of the overall kinase activity of RD and non-RD kinase
by a single site. Accordingly, T705 of the non-RD kinase XA21 is
essential for in vitro auto-phosphorylation, interaction with
downstream signaling components, and for XA21-mediated
resistance [65]. Similarly, a mutation of the corresponding residue
in FLS2 (T867) compromised its function in planta [67]. However,
in the case of the RD kinase BRI1 the phosphorylation of the
corresponding Thr (T880) is not required for its function [20].
These results suggest that the regulation of auto-phosphorylation
of non-RD kinases by phosphosites in the intra-cellular juxta-
membrane region may play an important role in the recruitment
of downstream signaling components, as suggested in [65].
Another difference between RD and non-RD RK seems to be
the requirement of kinase activity for complex formation with the
RD-RLK BAK1. We found that the kinase activity of neither
interaction partner is required for the ligand-induced interaction
of FLS2 or EFR with BAK1 (Figure 8). Optimal ligand-dependent
heteromerization could even be induced between double mutant
combinations of FLS2* or EFR* with BAK1* (Figure 8). These
results obtained after transient over-expression in N. benthamiana
nicely complement previous pharmacological studies in A. thaliana
cell cultures [30]. Treatment of cell cultures with the broad-range
kinase inhibitor K252a did not block FLS2-BAK1 complex
formation, but totally inhibited phosphorylation of either of the
interaction partners. Ligand-dependent conformational changes
thus seem sufficient to trigger heteromerization between the non-
RD kinases EFR and FLS2 with BAK1. Therefore, the interaction
of EFR and FLS2 with BAK1 is a requirement rather than a
consequence of detectable phosphorylation. This situation is in
stark contrast with the absolute requirement of the BRI1 kinase
BAK1 and Signaling Specificity
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planta [21].
Conclusions
BAK1 is able to dictate specificity of downstream signaling as
BAK1-5 nearly totally blocked FLS2- and EFR-mediated PTI
signaling but barely influenced cell death control and BRI1-
mediated BR signaling. Based on these results and the recent work
from Schulze and colleagues [30], we propose a model for the
mechanisms underlying EFR/FLS2 heteromerization with BAK1,
and the role of BAK1 in the establishment of PTI signaling. EFR
and FLS2 most likely exist in close proximity with BAK1 at the
plasma membrane in loose pre-formed complexes due to their
near instantaneous oligomerization after ligand binding [30].
Conformational changes triggered by ligand binding lead to the
stabilization of the complex. This interaction is kinase-indepen-
dent, but may lead to the activation of the EFR/FLS2 kinase
activity by BAK1 via trans-phosphorylation events. Phosphoryla-
tion of specific residues on EFR/FLS2 and/or BAK1 leads to the
recruitment of downstream signaling components that dictate the
specificity of the signaling output. In this model, BAK1 is not a
simple enhancer of the kinase activity of the ligand-binding RKs,
but is an integral part of the signaling pathway.
Future studies need to carefully address the role of kinase
activity of non-RD kinases for PTI signaling and final defence
outcomes. Therefore, careful qualitative and quantitative analyses
guided by mass-spectrometry of the phosphorylation status of
BAK1, BAK1-5, FLS2 and EFR in vitro and in vivo will shed more
light onto the complex regulatory mechanisms of these two model
non-RD PRRs by the regulatory RLK BAK1. These studies are
however technically challenging, as unlike BRI1, the kinase
activity of EFR is very weak and that of FLS2 is practically
negligible at least in vitro.
Methods
Plant material and methods
All mutants and transgenic lines used in this study were in the
background of A. thaliana ecotype Columbia (Col-0). The
Arabidopsis plants were grown on soil or MS salt medium
(Duchefa), 1% sucrose and 1% agar with a 10 H or 16 H
photoperiod at 20–22uC. The third backcross of bak1-5 with Col-0
was used for all experiments.
The mutants bak1-4, bkk1-1, bri1-301 were previously described
[24,27,47]. The double mutants bak1-4 bkk1-1, bak1-5 bkk1-1, bak1-
4 bri1-301, and bak1-5 bri1-301 were generated by crossing and
genotyped using the primers listed in Table S2.
bak1-5 marker design
For bak1-5 homozygous mutant identification a dCAPS marker
was designed using dCAPS Finder 2.0 [68]. The genomic region
around the bak1-5 mutation was PCR amplified using Taq
polymerase (Qiagen) and the primers listed in Table S2. The
corresponding product was cut with RsaI (NEB) and bak1-5
derived PCR products contained an additional RsaI site in
addition to the internal restriction control site.
Generation of transgenic plants
The genomic fragment of BAK1, including the promoter and the
coding region, in pDONR201 (Invitrogen) was a gift from B.
Kemmerling [23]. The corresponding point mutations for BAK1*,
BAK1-5, and BAK1-5* were introduced by point mutagenesis PCR
using primers given in Table S2. The PCR product was digested
with 1.5 ml DpnI (NEB) overnight and subsequently transformed
into Escherichia coli DH5a. The presence of the corresponding
mutations and the integrity of the genomic fragments were verified
by sequencing. The correct clones were used to transfer the inserts
into pGWB2 [69] using GATEWAY LR CLONASE II enzyme
(Invitrogen). The resulting constructs were verified by restriction
analysis and electroporated into Agrobacterium tumefaciens strain AglI.
All constructs were transformed into Arabidopsis mutant bak1-4
using the floral dipping method [70]. Transformants were selected
on MS agar medium containing 40 mg/ml hygromycin.
In vitro protein analysis
Molecular cloning. The kinase domain of BAK1 in the
pGEMTeasy vector was a gift from Sacco de Vries [71]. The
corresponding point mutations for BAK1*, BAK1-5, and BAK1-5*
were introduced as described above using primers given in Table
S2. The inserts of sequence verified clones were transferred into
pGEX-4T1 using EcoRI and XhoI (NEB) to generate N-terminal
GST fusion constructs.
The kinase domain of BRI1, FLS2 and EFR were PCR
amplified using the primers given in Table S2. The resulting
PCR products were cloned either into pOPINM or pOPINF [72]
using the IN-FUSION reagent (Clontech) to obtain N-terminal
MBP or His fusion constructs, respectively. The resulting
constructs were verified by restriction analysis and sequencing.
The corresponding point mutations of BRI1*, FLS2*, and EFR*
were obtained as described above using primers given in Table S2.
Recombinant protein purification. Recombinant fusion
proteins were produced in E. coli BL21 (Novagen), extracted using
BugBuster reagent (Novagen) containing 1 ml/ml Benzoase
(Novagen), 1 KU/ml Lysozyme (Novagen) and 150 ml/ml
protease inhibitor cocktail set II (Novagen) and the soluble
fraction was used to enrich for fusion proteins. GST-tagged fusion
proteins (GST-BAK1, GST-BAK1*, GST-BAK1-5, GST-BAK1-
5*) were enriched using Glutathione Sepharose Fast Flow (GE
Healthcare) according to the manufactures protocol. MBP-tagged
fusion proteins (MBP-BRI1, MBP-BRI1*, MBP-FLS2, MBP-
FLS*, MBP-EFR, MBP-EFR*) were enriched using Amylose
Resin (NEB) according to manufactures protocol. His-tag fusion
proteins (His-BRI1, His-BRI1*, His-EFR, His-EFR*) were
enriched using His-Bind Resin (Novagen) according to the
manufactures protocol. After elusion fusion proteins were
adjusted to the same concentration in 10% glycerol solution and
stored at 220uC until usage.
In vitro kinase assay. The fusion proteins were incubated in
30 ml kinase buffer (50 mM Tris, pH 7.5, 10 mM MgCl2,1 0m M
MnCl2, 1 mM DTT) in the presence of only 1 mM unlabeled ATP
or 1 mM unlabeled ATP and 183 kB of [
32P]-c-ATP for 30 min at
30uC with shaking at 900 rpm. The reactions were stopped by
adding 2xLDS loading buffer (Invitrogen). The phosphorylation
status of fusion proteins was analyzed by audioradiography after
separation of one-fourth of the in vitro kinase assay by SDS-PAGE
followed by western blotting, if not indicated otherwise. In
autophosphorylation assays 1 mg fusion protein for MBP- and
GST-tagged proteins and 5 mg for His-tagged proteins was
incubated with 1 mg of MBP (Fluka). In transphosphorylation
assays 1 mg of each fusion protein was used.
For Km determination, in vitro kinase assays were performed as
previously described [73]. Post electrophoresis, proteins were
transferred onto PVDF membranes. Subsequently, the mem-
branes were subjected to autoradiography using a FUJI Film
FLA5000 PhosphorImager (Fuji, Tokyo, Japan) to estimate
relative activities.
Phosphorylation site analysis. The indicated amount of
fusion proteins (GST-BAK1, GST-BAK1*, GST-BAK1-5, GST-
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membrane (Biorad). The immunoblots were blocked in 5% (w/v)
BSA (Sigma) in TBS-Tween (0.1%) for 1–2 H. Phospho-Serine/
Threonine sites were detected using anti-p-Thr (1:1000, Cell
Signaling Technology) overnight, followed by anti-mouse-HRP
conjugated secondary antibodies (1:5000, Sigma). Phospho-
Tyrosine sites were detected using anti-p-Tyr (1:2000, Cell
Signaling Technology) overnight, followed by anti-rabbit-HRP
conjugated secondary antibodies (1:5000, Sigma).
qRT-PCR
14-days-old seedlings grown for five days on MS plates and than
transferred to liquid MS were used for all gene induction studies.
RNA was extracted using RNeasy Plant Mini kit (Qiagen) followed
by DNase-treatment using Turbo DNA-free (Ambion) and
quantified with a Nanodrop spectrophotometer (Thermo scientif-
ic). cDNA was synthesized from 2.5 mg total RNA using
SuperScript III reverse transcriptase (Invitrogen). SybrGreen
master mix (Sigma) was used for qPCR reactions.
For defence gene induction analysis a triplicate of two seedlings
each was treated either with water, 100 nM elf18 or 100 nM flg22
for 0, 30, 60 and 180 min and pooled before harvesting. Gene
expression of At2g17740 (DC1-domain containing protein), At5g57220
(CYP81F2) and At1g51890 (LRR-RLK) was monitored by qPCR
analysis. The expression of each marker gene was normalized to
the internal reference gene At4g05320 (UBQ10) and plotted
relative to the Col-0 steady-state expression level.
For BR gene expression analysis a triplicate of two seedlings
each was treated with either mock solvent control or 2.5 mM BRZ
(Sigma) for 16 H over night. The next morning samples were
further treated with mock solvent control or 200 nM brassinolide
(SRICI) for another three hours before being pooled for
harvesting. Gene expression of At2g40610 (EXP8) and At4g38850
(SAUR-ACI) was monitored by qPCR analysis. The expression of
each gene was normalized to the internal reference gene
At5g15400 (U-box containing protein) and plotted relative to the
Col-0 double mock treated expression level.
Hypocotyl growth assay
Freshly harvested seeds were surface sterilized and stratified in
sterile water at 4uC for 4–6 days in the dark. Individual seeds were
put on K MS containing 0.8% phytoagar (Duchefa) without
hormone, with 100 nM BL or with 100 nM BRZ and left up-right
in the dark at 20–22uC. Hypocotyl length was measured after 5-
day incubation.
Bacterial infection assays
The P. syringae pv. tomato DC3000 COR
2 (Pto DC3000 COR
2)
[40] strain was grown in overnight culture in Kings B medium
supplemented with appropriate antibiotics. Cells were harvested
by centrifugation and pellets re-suspended in sterile water to
OD600=0.2. Immediately prior to spraying, Silwett L-77 was
added to bacteria to a concentration of 0.04% (v/v). Bacteria were
sprayed onto leaf surfaces until run-off and plants covered for 3
days. Samples were taken using a cork-borer (2 mm) to cut leaf
discs from 2 leaves per plant and 4 plants per genotype. Leaf discs
were ground in water, diluted and plated on TSA medium with
appropriate selection. Plates were incubated at 28uC and colonies
counted 2 days later.
MAP kinase assay
14-days-old seedlings were grown for five days on MS plates and
than transferred to liquid MS. Triplicates of two seedlings each
were treated with water, 100 nM elf18 or 100 nM flg22 for 0, 5
and 15 min before being pooled for harvest. Seedlings were
ground to fine powder in liquid nitrogen and solubilised in better
lacus buffer [50 mM Tris-HCl pH 7.5; 100 mM NaCl; 15 mM
EGTA; 10 mM MgCl2; 1 mM NaF; 1 mM Na2MoO4.2H2O;
0.5 mM NaVO3;3 0m Mb-glycerophosphate; 0.1% IGEPAL CA
630; 100 nM calyculin A (CST); 0.5 mM PMSF; 1% protease
inhibitor cocktail (Sigma, P9599)]. The extracts were centrifuged
at 16,0006g, the supernatant cleared by filtering through Mira-
cloth and 4xLDS loading buffer (Invitrogen) added. 40 mg of total
protein was separated by SDS-PAGE and blotted onto PVDF
membrane (Biorad). Immunoblots were blocked in 5% (w/v) BSA
(Sigma) in TBS-Tween (0.1%) for 1–2 H. The activated MAP
kinases were detected using anti-p42/44 MAPK primary antibod-
ies (1:1000, Cell Signaling Technology) overnight, followed by
anti-rabbit-HRP conjugated secondary antibodies (Sigma).
Seedling growth inhibition
Fresh harvested seeds were surface sterilized, sown on MS
media, stratified for 2 days at 4uC in the dark and put in the light.
Five-day-old seedlings were transferred into liquid MS with or
without the indicated amount of peptide and incubated for eight
further days. Dry weight of six replicates per treatment was
measured using a precision scale (Sartorius) and blotted relative to
untreated control.
ROS burst assay
Eight leaf discs (4 mm diameter) of at least four 3–4 week plants
were sampled using a cork borer and floated over night on sterile
water. The following day the water was replaced with a solution of
17 mg/ml (w/v) luminol (Sigma) and 10 mg/ml horseradish
peroxidase (Sigma) containing 100 nM elf18 or 100 nM flg22.
Luminescence was captured either using a Varioskan Flash
(Thermo Scientific) multiplate reader or Photek camera (East
Sussex, UK). The amount of relative light units might differ
depending on the light capturing apparatus used.
Transient expression in N. benthamiana
The whole coding sequence without the stop codon of FLS2,
EFR, BAK1 and BAK1-5 was PCR amplified using the primers
given in Table S2 and cloned into the pENTR-D/TOPO vector
using the pENTR Directional TOPO cloning kit (Invitrogen). The
resulting clones were verified by restriction analysis and sequence.
The kinase dead variants FLS2*, EFR* and BAK1* were generated
by point mutagenesis using the primers given in Table S2 and
sequence verified. The coding sequences of FLS2, FLS2*, EFR and
EFR* were transferred into pEarleyGate103 [74] using the method
described for Gateway vectors generating C-terminal GFP-His-tag
fusion constructs under the 35S promoter. The coding sequence of
BAK1, BAK1* and BAK1-5 were transferred into pGWB14
generating C-terminal HA-tag fusion constructs under the 35S
promoter. The CERK1p::CERK1-3xHA construct was previously
published [75]. The EFRp::EFR-3xHA construct, containing own
promoter plus coding region, was described previously with the
exception of using epiGreenB5 as binary vector [36]. All resulting
constructs were verified by restriction analysis and transformed
into A. tumefaciens strain GV3101.
The constructs of BAK1p::BAK1-eGFP or BAK1p::BAK1-5-eGFP,
containing own promoter plus coding regions, were PCR
amplified using primers given in Table S2. The resulting
constructs were cloned into pCR-Blunt-II-TOPO (Invitrogen)
and verified by sequencing. The inserts were released by digesting
with BsmBI and BamHI (NEB) and ligated into epiGreenB(eGFP)
digested with EcoRI and BamHI (NEB). Resulting constructs were
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AglI containing the pSOUP helper plasmid.
A. tumefaciens containing the indicated constructs were grown in
L medium supplemented with the appropriate antibiotics
overnight. Cultures were spun down and resuspended in 10 mM
MgCl2 to a final O.D.600=0.2-0.5. The indicated cultures were
mixed 1:1 and syringe infiltrated into 3-week-old N. benthamiana
leaves. After 2 dpi whole leaves were vacuum infiltrated with
water or 100 nM of the indicated peptide, incubated for 5 min
and harvested by freezing in liquid nitrogen.
Protein extraction and immunoprecipitation in N.
benthamiana
Leaves were ground to fine powder in liquid nitrogen and 5 ml
extraction buffer [50 mM Tris-HCl pH 7.5; 150 mM NaCl; 10%
glycerol; 10 mM DTT; 10 mM EDTA; 1 mM NaF; 1 mM
Na2MoO4.2H2O; 1% (w/v) PVPP; 1% (v/v) P9599 protease
inhibitor cocktail (Sigma); 1% (v/v) IGEPAL CA-630 (Sigma)]
added. Samples were cleared by centrifugation at 16.0006gf o r
15 min at 4uC and adjusted to 2 mg/ml total protein concen-
tration. Immunoprecipitation were performed on 1.5 ml total
protein by adding 20 ml GFPTrap-A beads (Chromotek) and
incubation at 4uC for 3–4 H. Beads were washed 4 times with
TBS containing 0.5% (v/v) IGEPAL CA-630, immunoprecipi-
tates eluted with 30 ml 2xLDS (Invitrogen) and heating at 70uC
for 10 min.
SDS-PAGE and immunoblotting
SDS-gels were prepared with either 7.5 or 10% cross-linking.
Gels were run at 80/150 V and proteins electroblotted onto
PVDF membrane at 235 mA (Biorad). Membranes were rinsed in
TBS and blocked in 5% (w/v) nonfat milk powder in TBST 0.1%
(w/v) for 1 H. Primary antibodies were diluted in blocking solution
to the following concentration and incubated overnight: anti-GFP
(AMS Biotechnology) 1:5000; anti-BAK1 1:500; anti-HA-HRP
(Santa Cruz) 1:2000; anti-FLS2 1:1000; anti-BRI1 1:1000.
Membranes were washed 3 times in TBST 0.1% (w/v) before
1 hour incubation with secondary antibodies anti-rabbit-HRP
(Sigma) 1:5000 or anti-rabbit-HRP (Ebioscience) 1:5000. Signals
were visualized using chemiluminescent substrate (Lumigen ECL,
GE Healthcare) before exposure to film (AGFA CP-BU).
Protein extraction and immunoprecipitation in
Arabidopsis
Leaves were ground to fine powder in liquid nitrogen and
extraction buffer [50 mM Tris-HCl pH 7.5; 150 mM NaCl; 10%
glycerol; 5 mM DTT; 2 mM EDTA; 1 mM NaF; 1 mM
Na2MoO4.2H2O; 1 mM PMSF (Sigma); 5 mM Na3VO4,1 %
(v/v) P9599 protease inhibitor cocktail (Sigma); 1% (v/v) IGEPAL
CA-630 (Sigma)] added. Samples were cleared by centrifugation at
16.0006g for 15 min at 4uC and adjusted to 2 mg/ml total
protein concentration. Immunoprecipitations were performed on
1.5 ml total protein by adding 20 ml true-blot anti-rabbit Ig beads
(Ebioscience), 15 ml antibody and incubation at 4uC for 3–4 H.
Beads were washed 4 times with TBS containing 0.5% (v/v)
IGEPAL CA-630, immunoprecipitates eluted with 50 ml 2xLDS
(Invitrogen) and heated at 70uC for 10 min.
Supporting Information
Figure S1 bak1-5, but not bak1-4, is strongly impaired in flg22-
and elf18-induced SGI. SGI of Col-0, bak1-4 and bak1-5 in the
presence of 1 mM flg22 or elf18. Fresh weight is represented
relative to untreated control. Results are average 6 s.e (n=6).
This experiment was repeated three times with similar results.
(PDF)
Figure S2 BAK1-5 is causative for the reduced elf18-induced
ROS burst and behaves in a semi-dominant manner. A.
Expression of BAK1 and BAK1-5 in transgenic plants in the
bak1-4 background. Immunoblot of total protein from Col-0, bak1-
4 pBAK1::BAK1, bak1-4 pBAK1::BAK1-5 and bak1-4 using anti-
BAK1 antibody. Immunoblot, upper panel; Coomassie colloidal
blue stained membrane, lower panel. B. The bak1-5 mutation is
causative for the compromised elf18-induced ROS burst. ROS
burst in leaves of Col-0, bak1-4, bak1-5, bak1-4 pBAK1::BAK1 and
bak1-4 pBAK1::BAK1-5 plants treated with 100 nM elf18. Results
are average 6 s.e. (n=8). C. bak1-5 behaves in a semi-dominant
negative manner. ROS burst in leaves of Col-0, bak1-4, bak1-5,
bak1-56bak1-4 F1 and bak1-56Col-0 F1 plants treated with
100 nM elf18. Results are average 6 s.e. (n=8). These
experiments were repeated at least twice with similar results.
(PDF)
Figure S3 Reduced steady-state defence genes expression in
bak1-5. Gene expression of At2g17740 (left), CYP81F2 (middle) and
At1g51890 (right) in seedlings of Col-0, bak1-4 and bak1-5 was
measured by qPCR analysis. Results are average 6 s.e. (n=3).
This experiment was repeated four times with similar results.
(PDF)
Figure S4 The expression of BAK1-5 compromises disease
resistance to Pto DC3000 COR
2. Five week old plants Col-0, bak1-
4, bak1-5, bak1-4 pBAK1::BAK1 and bak1-4 pBAK1::BAK-5 were
spray-infected with Pto DC3000 COR
2 O.D.600 nm=0.2, covered
at high humidity for 3 days and left for another 2 days for disease
symptoms to develop. Scale bar represents 4 cm.
(PDF)
Figure S5 The expression of BAK1-5 rescues the semi-dwarf
phenotype of bak1-4. Picture of representative individuals of five-
week-old Col-0, bak1-4, bak1-5, bak1-4 pBAK1::BAK1 and bak1-4
pBAK1::BAK-5 plants grown under short-day conditions. Scale bar
represents 4 cm. This experiment was repeated at least three times
with similar results.
(PDF)
Figure S6 bkk1-1 bak1-5 does not show any early senescence
phenotypes. Picture of representative individuals of six-week-old
Col-0, bak1-4, bak1-5, bkk1-1 and bak1-5 bkk1-1 plants grown under
short-day conditions. Scale bar represents 5 cm. This experiment
was repeated twice with similar results.
(PDF)
Figure S7 BAK1-5 shows an enhanced interaction with FLS2.
Co-immunoprecipitation of BAK1 or BAK1-5 with FLS2 in Col-0
or bak1-5 plants treated or not with 100 nM flg22 for 5 min,
respectively. Total proteins (T) were subjected to immunoprecip-
itation (IP) with anti-BAK1 antibodies and IgG beads followed by
immunoblot analysis using anti-FLS2 or anti-BAK1 antibodies.
This experiment was repeated twice with similar results.
(PDF)
Figure S8 BAK1 or BAK1-5 does not interact with CERK1.
Co-immunoprecipitation CERK1-HA3 with either BAK1-GFP or
BAK1-5-GFP after transient expression in N. benthamiana leaves.
Leaves were treated or not with 100 mg/mL chitin for 5 min.
Total protein (T) was subjected to immunoprecipitation with GFP-
Trap beads followed by immunoblot analysis using anti-GFP or
anti-HA antibodies. The asterisk indicates an unspecific band.
(PDF)
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in kinase activity. Relative kinase activity measured as auto-
phosphorlyation level of BAK1 or BAK1-5, respectively.
(PDF)
Figure S10 FLS2 is an inactive kinase in vitro. In vitro kinase assay
using His or N-terminal His-tagged FLS2, FLS2*, BRI1 and
BRI1* CD. Note that ten times more FLS2 and FLS2* CD was
loaded compared to BRI1 and BRI1* CD. Autoradiogram, upper
panel; Coomassie colloidal blue stained membrane, lower panel
(PDF)
Figure S11 Expression of BAK1, BAK1-5, BAK1*, and BAK1-
5* in transgenic plants in the bak1-4 background. Immunoblot of
total proteins from Col-0, bak1-4 pBAK1::BAK1, bak1-4 pBAK1::
BAK1*, bak1-4 pBAK1::BAK1-5, pBAK1::BAK1-5* and bak1-4 using
anti-BAK1 antibodies. Immunoblot, upper panel; Coomassie
colloidal blue stained membrane, lower panel.
(PDF)
Figure S12 The kinase activity of EFR is required for elf18-
induced ROS burst. ROS burst in N. benthamiana leaves transiently
expressing FLS2-GFP-His, EFR-GFP-His,o rEFR*-GFP-His treated
with 100 nM elf18. Results are average 6 s.e. (n=8).
(PDF)
Table S1 The quantitative kinase out-put of BAK1 is not
correlated with its ability to function in PTI or BR signaling
pathways. The number of ‘‘2’’ indicates the severity of
impairment of BAK1 specific function.
a in vitro kinase activity of
BAK1 variants, relative impairment partially approximated.
b Impairment in PTI signaling was only measured as the respective
BAK1 variant’s ability to rescue the impairment of bak1-4 bkk1-1
in flg22-triggered SGI.
1 ref. Wang et al. 2008 [21].
2 ref. Oh et al.
2010 [34].
3 ref. Li et al. 2002 [19], Wang et al. 2008 [21] and
present study.
(DOC)
Table S2 Primers used in this study.
(DOC)
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